4//SEC Filing
Began Marc A 4
Accession 0001415889-22-005932
CIK 0000815094other
Filed
May 30, 8:00 PM ET
Accepted
May 31, 5:31 PM ET
Size
19.1 KB
Accession
0001415889-22-005932
Insider Transaction Report
Form 4
ABIOMED INCNASD
Began Marc A
VP & General Counsel
Transactions
- Award
Common Stock, $.01 par value
2022-05-26+4,680→ 15,541 total - Award
Common Stock, $.01 par value
2022-05-29+2,200→ 17,741 total - Tax Payment
Common Stock, $0.01 par value
2022-05-29$266.34/sh−480$127,843→ 16,285 total - Tax Payment
Common Stock, $0.01 par value
2022-05-29$266.34/sh−976$259,948→ 16,765 total
Holdings
Stock Option (Right to Buy)
Exercise: $283.88From: 2022-05-25Exp: 2031-05-25→ Common Stock- 7,000
Stock Option (Right to Buy)
Exercise: $266.39From: 2020-05-30Exp: 2029-05-30→ Common Stock (0 underlying) - 5,125
Stock Option (Right to Buy)
Exercise: $223.90From: 2021-05-29Exp: 2030-05-29→ Common Stock (0 underlying)
Footnotes (5)
- [F1]Consists of restricted stock units granted to the reporting person. One third of the restricted stock units will vest and the underlying shares will be issued to the reporting person on each of May 26, 2023, May 26, 2024 and May 26, 2025, so long as the reporting person continues to be employed by the issuer on the vesting dates.
- [F2]Represents shares of common stock underlying performance-based awards of restricted stock units granted to this reporting person on May 29, 2020. One hundred percent of these restricted stock units vested on May 29, 2022 (into an equal number of shares of common stock) based on the issuer's achievement of a certain performance milestone.
- [F3]Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards.
- [F4]Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
- [F5]These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
Documents
Issuer
ABIOMED INC
CIK 0000815094
Entity typeother
Related Parties
1- filerCIK 0001821352
Filing Metadata
- Form type
- 4
- Filed
- May 30, 8:00 PM ET
- Accepted
- May 31, 5:31 PM ET
- Size
- 19.1 KB